Skip to content

Update Evaluation Report for Omeprazole-Model#474

Open
osp-reports-creator wants to merge 2 commits into
developfrom
test-12.3-hotfix-1-Omeprazole-Model
Open

Update Evaluation Report for Omeprazole-Model#474
osp-reports-creator wants to merge 2 commits into
developfrom
test-12.3-hotfix-1-Omeprazole-Model

Conversation

@osp-reports-creator

Copy link
Copy Markdown
Collaborator

Tools

Tool Version Url
R 4.5.2 NA
ospsuite-R 12.4.3 NA
Reporting Engine 2.4.7 NA
RUtils 1.11.1 NA
TLF 1.6.2 NA
rClr NA NA
rSharp 1.2.1 NA
Qualification Runner 12.3.135 https://github.com/Open-Systems-Pharmacology/QualificationRunner/releases/download/v12.3.135/Qualification-Runner.12.3.135.zip
Qualification Framework 3.7 NA
PK-Sim 12.3.172 https://github.com/Yuri05/Create-Qualification-Reports/releases/download/test-RE-2.4.7/PKSim.Portable.12.3.172.zip

All evaluated models

Execute Repository name Released version Snapshot name Folder name Workflow name Additional projects
true 7E3-Model 1.0 7E3 7E3
true Alfentanil-Model 3.0 Alfentanil-Model Alfentanil Alfentanil-Pediatrics/v2.0/Alfentanil-Pediatrics.json
true Alprazolam-Model 2.0 Alprazolam-Model Alprazolam
true Amikacin-Model 2.0 Amikacin-Model Amikacin Amikacin-Pediatrics/v1.0/Amikacin-Pediatrics.json
true Atazanavir-Model 2.0 Atazanavir-Model Atazanavir
true BAY794620-Model 1.0 BAY794620 BAY794620
true CDA1-Model 1.0 CDA1 CDA1
true Carbamazepine-Model 2.0 Carbamazepine-Model Carbamazepine
true Cimetidine-Model 2.0 Cimetidine-Model Cimetidine
true Clarithromycin-Model 2.0 Clarithromycin-Model Clarithromycin
true Dapagliflozin-Model 2.0 Dapagliflozin-Model Dapagliflozin
true Digoxin-Model 2.0 Digoxin-Model Digoxin Digoxin-Pediatrics/v1.1/Digoxin_Pediatrics.json
true Efavirenz-Model 2.0 Efavirenz-Model Efavirenz
true Erythromycin-Model 2.0 Erythromycin-Model Erythromycin
true Ethinylestradiol-Model 2.0 Ethinylestradiol-Model Ethinylestradiol
true Felodipine-Model 2.0 Felodipine-Model Felodipine
true Fluconazole-Model 2.0 Fluconazole-Model Fluconazole
true Fluvoxamine-Model 2.0 Fluvoxamine-Model Fluvoxamine
true Inulin-Model 1.0 Inulin Inulin
true Itraconazole-Model 2.0 Itraconazole-Model Itraconazole
true MEDI524-Model 1.0 MEDI524 MEDI524
true MEDI524YTE-Model 1.0 MEDI524YTE MEDI524YTE
true Mefenamic-acid-Model 2.0 Mefenamic_acid-Model Mefenamic_acid
true Mexiletine-Model 2.0 Mexiletine-Model Mexiletine
true Midazolam-Model 2.0 Midazolam-Model Midazolam
true Moclobemide-Model 2.0 Moclobemide-Model Moclobemide
true Montelukast-Model 2.0 Montelukast Montelukast Montelukast-Pediatrics/v1.0/Montelukast-Pediatrics.json
true Omeprazole-Model 2.0 Omeprazole-Model Omeprazole
true Propofol-Model 1.0 Propofol Propofol Propofol-Pediatrics/v1.0/Propofol-Pediatrics.json
true Raltegravir-Model 2.0 Raltegravir-Model Raltegravir Raltegravir-Pediatrics/v1.0/Raltegravir-Pediatrics.json
true Rifampicin-Model 2.0 Rifampicin-Model Rifampicin
true S-Mephenytoin-Model 2.0 S_Mephenytoin-Model S-Mephenytoin
true Sildenafil-Model 2.0 Sildenafil-Model Sildenafil
true Sufentanil-Model 2.0 Sufentanil Sufentanil Sufentanil-Pediatrics/v1.0/Sufentanil-Pediatrics.json
true Tefibazumab-Model 1.0 Tefibazumab Tefibazumab
true Tizanidine-Model 2.0 Tizanidine-Model Tizanidine
true Triazolam-Model 2.0 Triazolam-Model Triazolam
true Vancomycin-Model 2.0 Vancomycin Vancomycin Vancomycin-Pediatrics/v1.0/Vancomycin-Pediatrics.json
true Verapamil-Model 2.2 Verapamil-Model Verapamil
true dAb2-Model 1.0 dAb2 dAb2

@osp-reports-creator osp-reports-creator force-pushed the test-12.3-hotfix-1-Omeprazole-Model branch from 49e0911 to 14be16f Compare July 3, 2026 15:19
@coderabbitai

coderabbitai Bot commented Jul 3, 2026

Copy link
Copy Markdown
Contributor

Warning

Review limit reached

@osp-reports-creator, you've reached your PR review limit, so we couldn't start this review.

Next review available in: 44 minutes

Enable usage-based reviews in Billing to review now. Otherwise, wait until the next included review is available.
You're only billed for reviews past your plan's rate limits ($0.25/file).

How can I continue?

After more reviews become available, a review can be triggered using the @coderabbitai review command as a PR comment. Alternatively, push new commits to this PR.

To avoid repeated limits, reduce automatic review volume by pausing incremental auto-reviews earlier, using label-based review opt-in, excluding WIP or generated PR titles, or requesting reviews manually when the PR is ready. If your team needs uninterrupted high-volume reviews, an organization admin can enable usage-based reviews.

How do review limits work?

CodeRabbit enforces per-developer PR review limits for each organization. Most developers receive the normal plan review availability.

For paid Pro and Pro+ PR reviews, CodeRabbit uses adaptive limits for sustained high-volume activity. When a developer's recent PR review activity reaches the 95th percentile or higher among CodeRabbit users, additional reviews become available more gradually as earlier reviews age out of the rolling window.

Please refer docs for additional details.

Review details
⚙️ Run configuration

Configuration used: Organization UI

Review profile: CHILL

Plan: Pro

Run ID: 006b212b-45d3-4f33-9673-0f75ca73b3b5

📥 Commits

Reviewing files that changed from the base of the PR and between ec872d8 and 14be16f.

⛔ Files ignored due to path filters (43)
  • Omeprazole/Omeprazole_evaluation_report.pdf is excluded by !**/*.pdf
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/2_gof_plot_predictedVsObserved.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/3_gof_plot_residualsOverTime.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/5_gof_plot_predictedVsObserved.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/6_gof_plot_residualsOverTime.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/8_gof_plot_predictedVsObserved.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/008_section_diagnostics-plots/9_gof_plot_residualsOverTime.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/10_time_profile_plot_Omeprazole_E_9___Esomeprazole_PO_40_mg_oral_solution__5d_QD__Hassan_Alin2005_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/12_time_profile_plot_Omeprazole_Esomeprazole_PO_40_mg_capsule___5d_QD__Wilder_Smith2005___with_Fit_formulation.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/14_time_profile_plot_Omeprazole_R_3___R_omeprazole_po_15_mg___7d_QD__Andersson2000____EM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/15_time_profile_plot_Omeprazole_R_1___R_omeprazole_po_20_mg___5d_QD__Hassan_Alin2005_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/16_time_profile_plot_Omeprazole_R_2___R_omeprazole_po_40_mg___5d_QD__Hassan_Alin2005_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/17_time_profile_plot_Omeprazole_R_4___R_omeprazole_po_60_mg___7d_QD__Andersson2000____PM___CL_Fit.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/18_time_profile_plot_Omeprazole_O5__Omeprazole_iv_10mg.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/19_time_profile_plot_Omeprazole_O1__Omeprazole_iv_10_mg___SD__Regardh1990____PM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/1_time_profile_plot_Omeprazole_E_1_Esomeprazole_IV_20_mg___5d_QD__Hassan_Alin2000_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/20_time_profile_plot_Omeprazole_O4__Omeprazole_iv_20_mg___SD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/21_time_profile_plot_Omeprazole_O2__Omeprazole_iv_20_mg___SD_in_PM__Uno2007_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/22_time_profile_plot_Omeprazole_O3__Omeprazole_iv_40_mg___SD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/23_time_profile_plot_Omeprazole_O6__Omeprazole_iv_80mg.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/2_time_profile_plot_Omeprazole_E_2__Esomeprazole_IV_40_mg___5d_QD__Hassan_Alin2000__Wilder_Smith2005_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/34_time_profile_plot_Omeprazole_O92__Omeprazole_po_60_mg___oral_solution___MD_in_PM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/3_time_profile_plot_Omeprazole_E_4__Esomeprazole_IV_80mg_30min__4mg_h___SD__Rohss2007_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/4_time_profile_plot_Omeprazole_E_3__Esomeprazole_IV_40mg_30min__8mg_h____Rohss2007_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/5_time_profile_plot_Omeprazole_E_5__Esomeprazole_IV_80mg_30min__8mg_h___SD__Rohss2007____pred.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/6_time_profile_plot_Omeprazole_E_6__Esomeprazole_IV_120mg_30min__8mg_h___SD__Rohss2007_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/7_time_profile_plot_Omeprazole_E_7__Esomeprazole_IV_120mg_2h__8mg_h___SD__Rohss2007__.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/010_section_model-building/9_time_profile_plot_Omeprazole_E_8___Esomeprazole_PO_20_mg_oral_solution__5d_QD__Hassan_Alin2005__.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/11_time_profile_plot_Omeprazole_E_11___SD_in_EM___Esomeprazole_PO_40_mg__FDA___same_schema_as_E_9.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/13_time_profile_plot_Omeprazole_E_14___MD_in_PM__no_2C19CL____Esomeprazole_PO_60_mg_solution__Andersson2000_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/24_time_profile_plot_Omeprazole_O9__Omeprazole_po_15_mg___oral_solution____Andersson2000____MD_in_EM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/25_time_profile_plot_Omeprazole_O8__Omeprazole_po_20_mg___oral_solution___SD_and_MD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/26_time_profile_plot_Omeprazole_O8__Omeprazole_po_20_mg___oral_solution___SD_and_MD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/27_time_profile_plot_Omeprazole_O8__Omeprazole_po_20_mg___5d_QD___capsule.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/28_time_profile_plot_Omeprazole_O8__Omeprazole_po_20_mg___5d_QD___capsule.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/29_time_profile_plot_Omeprazole_O8__Omeprazole_po_20_mg___5d_QD___capsule___PM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/30_time_profile_plot_Omeprazole_O7__Omeprazole_po_40mg___oral_solution__SD_and_MD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/31_time_profile_plot_Omeprazole_O_1__pop___Omeprazole_po_20_mg___DDI_without_moclobemide____Cho2002_.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/32_time_profile_plot_Omeprazole_O_1__pop___Omeprazole_po_20_mg___DDI_without_moclobemide____Cho2002__pm.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/33_time_profile_plot_Omeprazole_O7__Omeprazole_po_40_mg___5d_QD_japanese___capsule___EM.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/35_time_profile_plot_Omeprazole_O91__Omeprazole_po_80_mg___oral_solution___SD.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/36_time_profile_plot_Omeprazole_O_9__Omeprazole_DDI_without_fluvoxamine.png is excluded by !**/*.png
  • Omeprazole/images/006_section_results-and-discussion/009_section_ct-profiles/011_section_model-verification/8_time_profile_plot_Omeprazole_E_13___MD_in_EM___Esomeprazole_PO_15_mg_solution__Andersson2000_.png is excluded by !**/*.png
📒 Files selected for processing (2)
  • Omeprazole/Omeprazole-Model.pksim5
  • Omeprazole/Omeprazole_evaluation_report.md
✨ Finishing Touches
🧪 Generate unit tests (beta)
  • Create PR with unit tests
  • Commit unit tests in branch test-12.3-hotfix-1-Omeprazole-Model

Thanks for using CodeRabbit! It's free for OSS, and your support helps us grow. If you like it, consider giving us a shout-out.

❤️ Share

Comment @coderabbitai help to get the list of available commands.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment

Labels

None yet

Projects

None yet

Development

Successfully merging this pull request may close these issues.

2 participants